Key result
Procedural IV fluid administration of ≥1400 mL during atrial fibrillation ablation was associated with increased odds of early incident heart failure (OR 2.21; 95% CI 1.03-4.70; p=0.04).
Why the study?
Catheter ablation is increasingly used for AF symptoms, but early incident acute heart failure postablation can increase resource utilization.
Does procedural IV fluid administration increase the risk of early incident acute heart failure in patients undergoing catheter ablation for atrial fibrillation?
Cohort (n=286)
Yes
Does procedural IV fluid administration increase the risk of early incident acute heart failure in patients undergoing catheter ablation for atrial fibrillation?
Greater procedural IV fluid administration (≥1400 mL) during AF ablation is associated with an increased risk of early incident acute heart failure, suggesting careful fluid management is needed.
Supports careful fluid management in AF ablation; leaves open whether limiting volume prevents early HF.
INTRODUCTION: Catheter ablation is an increasingly utilized procedure to manage symptoms of atrial fibrillation (AF). However, early incident acute heart failure (HF) can lead to increased resource utilization postablation. METHODS: In the Multicenter prospective Cohort study examining Left Atrial Pressure and the risk of early incident Heart failure after catheter ablation of Atrial Fibrillation (CLAPHAF) study, we examined risk factors for HF after AF ablation. RESULTS: Of the 286 subjects enrolled, 11.8% of subjects experienced incident HF a median 14 (12, 31) days from ablation. Risk factors for incident HF were persistent AF, recurrent post ablation AF, procedural IV fluid administration, longer case duration, and lower procedural blood pressures. A threshold of 1400 mL fluid administration had 2.21 odds ratio increase in incident HF (1.03-4.70, p = 0.04). The secondary endpoint of AF-free HF correlated with chronic kidney disease, lack of class 3 antiarrhythmic drug use, longer procedure duration, and increased IV fluid administration. Administration of ≥1400 mL corresponded with a 3.00 odds ratio for incident AF-free HF (1.03-8.72, p = 0.04). Multivariable analysis revealed no independent risk factors for HF or AF-free HF. CONCLUSIONS: In this prospective, multicenter cohort study, greater procedural IV fluid administration was a consistent risk factor for early incident HF after AF ablation, independent of recurrent AF. Low blood pressure during the case should perhaps trigger more pressor use and less fluid use in this population with impaired atrial function. A threshold of 1400 mL IV fluid administration is reasonable to consider periprocedural diuretic titration.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2025) conducted a cohort in Atrial fibrillation (n=286). Procedural IV fluid administration ≥1400 mL vs. <1400 mL IV fluid administration was evaluated on Early incident acute heart failure (OR 2.21, 95% CI 1.03-4.70, p=0.04). Procedural IV fluid administration of ≥1400 mL during atrial fibrillation ablation was associated with increased odds of early incident heart failure (OR 2.21; 95% CI 1.03-4.70; p=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: